MOLECULIN BIOTECH INC's ticker is MBRX and the CUSIP is 60855D200. A total of 26 filers reported holding MOLECULIN BIOTECH INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1 | -99.9% | 1,792 | 0.0% | 0.00% | – |
| Q3 2022 | $1,000 | -50.0% | 1,792 | 0.0% | 0.00% | – |
| Q2 2022 | $2,000 | -50.0% | 1,792 | -35.5% | 0.00% | – |
| Q1 2022 | $4,000 | -20.0% | 2,777 | 0.0% | 0.00% | – |
| Q4 2021 | $5,000 | -37.5% | 2,777 | 0.0% | 0.00% | – |
| Q3 2021 | $8,000 | -20.0% | 2,777 | -6.5% | 0.00% | – |
| Q2 2021 | $10,000 | -16.7% | 2,969 | 0.0% | 0.00% | – |
| Q1 2021 | $12,000 | – | 2,969 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 1,040,529 | $3,122,000 | 1.00% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 23,484 | $70,000 | 0.01% |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 27,400 | $82,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 175 | $1,000 | 0.00% |
| NORTHERN TRUST CORP | 50,731 | $152,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| UBS Group AG | 1,403 | $4,000 | 0.00% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 20,198 | $61,000 | 0.00% |
| OSAIC HOLDINGS, INC. | 801 | $2,000 | 0.00% |
| Rockefeller Capital Management L.P. | 2,777 | $8,000 | 0.00% |